Investment thesis
Sound Bioventures invests in specialty therapeutics companies at or approaching the clinical stage, working across Europe and the United States. Based in Malmö with additional offices in Stockholm and Hellerup, it backs novel medicines addressing unmet medical needs and describes itself as a straightforward, transparent and long-term co-investor.
Past investments
| Company | Round | Date | Round size |
|---|---|---|---|
| AnaCardio Stockholm, Sweden | Series B | Sep 2026 | €62.5M |
| Breye Therapeutics Hørsholm, Denmark | Series A | Sep 2026 | €67.5M |
| BOOST Pharma Stockholm, Sweden | - | Nov 2025 | €3.1M |